Results 211 to 220 of about 9,802 (262)

Vascular and Lymphatic Dysregulation via Non-EndoMT Col2a1 Signaling in Bisphosphonate-Related Osteonecrosis of the Jaw

Shi Y, Sun H, Guo Z, Liu X, Pei X, Wang J, Yu F, Peng X, Yuan Q, Kusumbe AP, Chen J.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bisphosphonate-associated osteonecrosis of the jaw

Menopause International, 2007
The term 'osteonecrosis of the jaw' is typically used to describe the exposure of bone within the oral cavity. These lesions are often painful and can result in pathological fracture and disfigurement in severe cases. Infection and dental extractions commonly precede presentation, although lesions can occur spontaneously.
Neil, Basu, David M, Reid
openaire   +3 more sources

Bisphosphonate-Associated Osteonecrosis of the Jaw

New England Journal of Medicine, 2006
A 54-year-old man with a 3-year history of IgG myeloma, complicated by hypercalcemia, who was being treated with dexamethasone, lenalidomide, filgrastim, darbepoetin alfa, and pamidronate, presented with a 1-month history of severe bilateral jaw pain.
Nathaniel Treister, Sook-Bin Woo
semanticscholar   +4 more sources

Bisphosphonate-associated osteonecrosis of the jaw: systematic review

Minerva Stomatologica, 2020
Objective The purpose of this systematic review was to determine the possible risk factors related to pathophysiology of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) and identify adequate treatment strategies available and success rates. Evidence acquisition We performed a search for publications about the treatment of BRONJ, published ...
Ferreira Jr., Luiz H., Mendonça Jr., Kedson D., de Souza, Jessica CHAVES, dos Reis, Danyella C. SOARES, do Carmo Faleiros Veloso Guedes, Cizelene, de Souza Castro Filice, Letícia, Bruzadelli Macedo, Sérgio, Soares Rocha, Flaviana   +7 more
openaire   +2 more sources

Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis

Supportive Care in Cancer, 2006
Prevalence of bisphosphonate-associated osteonecrosis of the jaws within the catchment area of a university hospital maxillofacial unit and to review the outcome of treatment.In a retrospective study, all patients with osteonecrosis, osteomyelitis and osteoradionecrosis treated in the period from January 2000 to March 2005 in the department for Maxillo
Christian, Walter, Knut A, Grötz, Martin, Kunkel, Bilal, Al-Nawas   +3 more
openaire   +3 more sources

Bisphosphonate-associated osteonecrosis of the jaw

Minerva Dental and Oral Science, 2021
The purpose of this systematic review was to determine the possible risk factors related to pathophysiology of bisphosphonate-related osteonecrosis of the jaw (BRONJ) and identify adequate treatment strategies available and success rates.We performed a search for publications about the treatment of BRONJ, published between 2003 and 2018 in the PubMed ...
Luiz H, Ferreira Jr, Kedson D, Mendonça Jr, Jessica, Chaves de Souza, Danyella C, Soares Dos Reis, Cizelene, do Carmo Faleiros Veloso Guedes, Letícia, de Souza Castro Filice, Sérgio, Bruzadelli Macedo, Flaviana, Soares Rocha   +7 more
openaire   +2 more sources

Intravenous Bisphosphonate–Associated Osteonecrosis of the Jaw

Journal of Periodontology, 2007
Background: Bisphosphonates have received attention in the dental and medical scientific literature because of spontaneous necrosis of the jaw subsequent to their use. As the population ages, the use of these medications is increasing; the medical benefits seem to outweigh the risk for osteonecrosis of the jaw (ONJ).Methods: A 71‐year‐old white male ...
Thomas A, Statz, Janet M, Guthmiller, Lewis A, Humbert, Georgia K, Johnson   +3 more
openaire   +2 more sources